114 related articles for article (PubMed ID: 18235934)
21. Estrogen and alendronate therapies may prevent the influence of estrogen deficiency on the tooth-supporting alveolar bone: a histometric study in rats.
Duarte PM; Gonçalves P; Casati MZ; de Toledo S; Sallum EA; Nociti FH
J Periodontal Res; 2006 Dec; 41(6):541-6. PubMed ID: 17076779
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of 5-fluorouracil anabolism by methotrexate and trimetrexate in two rat solid tumor models, Walker 256 carcinosarcoma and Novikoff hepatoma, as evaluated by 19F-magnetic resonance spectroscopy.
Katzir I; Shani J; Wolf W; Chatterjee-Parti S; Berman E
Cancer Invest; 2000; 18(1):20-7. PubMed ID: 10701363
[TBL] [Abstract][Full Text] [Related]
23. Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis.
Kusamori K; Katsumi H; Abe M; Ueda A; Sakai R; Hayashi R; Hirai Y; Quan YS; Kamiyama F; Sakane T; Yamamoto A
J Bone Miner Res; 2010 Dec; 25(12):2582-91. PubMed ID: 20533374
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effect of alendronate on bone resorption of autogenous free bone grafts in rats.
Altundal H; Sayrak H; Yurtsever E; Göker K
J Oral Maxillofac Surg; 2007 Mar; 65(3):508-16. PubMed ID: 17307600
[TBL] [Abstract][Full Text] [Related]
25. Aprotinin and growth of Walker 256 carcinosarcoma in the rat.
Thomson AW; Pugh-Humphreys RG; Horne CH; Tweedle DJ
Br J Cancer; 1977 Apr; 35(4):454-60. PubMed ID: 300627
[TBL] [Abstract][Full Text] [Related]
26. Treatment trial of multicentric reticulohistiocytosis with a combination of predonisolone, methotrexate and alendronate.
Satoh M; Oyama N; Yamada H; Nakamura K; Kaneko F
J Dermatol; 2008 Mar; 35(3):168-71. PubMed ID: 18346261
[No Abstract] [Full Text] [Related]
27. Effects of enteral and parenteral nutrition on tumor response to chemotherapy in experimental animals.
Daly JM; Reynolds HM; Copeland EM; Dudrick SJ
J Surg Oncol; 1981; 16(1):79-86. PubMed ID: 6780732
[TBL] [Abstract][Full Text] [Related]
28. Effect of sodium alendronate on alveolar bone resorption in experimental periodontitis in rats.
Menezes AM; Rocha FA; Chaves HV; Carvalho CB; Ribeiro RA; Brito GA
J Periodontol; 2005 Nov; 76(11):1901-9. PubMed ID: 16274309
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate.
Cohen H; Alferiev IS; Mönkkönen J; Seibel MJ; Pinto T; Ezra A; Solomon V; Stepensky D; Sagi H; Ornoy A; Patlas N; Hägele G; Hoffman A; Breuer E; Golomb G
Pharm Res; 1999 Sep; 16(9):1399-406. PubMed ID: 10496656
[TBL] [Abstract][Full Text] [Related]
30. Effect of alendronate on bone-specific alkaline phosphatase on periodontal bone loss in rats.
Goes P; Melo IM; Dutra CS; Lima AP; Lima V
Arch Oral Biol; 2012 Nov; 57(11):1537-44. PubMed ID: 23062673
[TBL] [Abstract][Full Text] [Related]
31. Long-term effects of local pretreatment with alendronate on healing of replanted rat teeth.
Komatsu K; Shimada A; Shibata T; Shimoda S; Oida S; Kawasaki K; Nifuji A
J Periodontal Res; 2008 Apr; 43(2):194-200. PubMed ID: 18302622
[TBL] [Abstract][Full Text] [Related]
32. The bisphosphonate alendronate improves the damage associated with trinitrobenzenesulfonic acid-induced colitis in rats.
Ballester I; Daddaoua A; López-Posadas R; Nieto A; Suárez MD; Zarzuelo A; Martínez-Augustin O; Sánchez de Medina F
Br J Pharmacol; 2007 May; 151(2):206-15. PubMed ID: 17375077
[TBL] [Abstract][Full Text] [Related]
33. Alendronate therapy in cyclosporine-induced alveolar bone loss in rats.
Spolidorio LC; Marcantonio E; Spolidorio DM; Nassar CA; Nassar PO; Marcantonio RA; Rossa C
J Periodontal Res; 2007 Oct; 42(5):466-73. PubMed ID: 17760825
[TBL] [Abstract][Full Text] [Related]
34. [The efficacy of intravenous alendronate for osteoporosis in patients with severe motor intellectual disabilities].
Kaga Y; Ishii S; Kuroda I; Kamiya Y; Nakamura K; Kanemura H; Sugita K; Aihara M
No To Hattatsu; 2017 Mar; 49(2):113-9. PubMed ID: 30113151
[TBL] [Abstract][Full Text] [Related]
35. In vivo synergy of vitamin K3 and methotrexate in tumor-bearing animals.
Gold J
Cancer Treat Rep; 1986 Dec; 70(12):1433-5. PubMed ID: 3791255
[TBL] [Abstract][Full Text] [Related]
36. Effects of alendronate on rate of distraction in rabbit mandibles.
Tekin U; Tüz HH; Onder E; Ozkaynak O; Korkusuz P
J Oral Maxillofac Surg; 2008 Oct; 66(10):2042-9. PubMed ID: 18848100
[TBL] [Abstract][Full Text] [Related]
37. Combined local application of tetracycline and bisphosphonate reduces alveolar bone resorption in rats.
Yaffe A; Herman A; Bahar H; Binderman I
J Periodontol; 2003 Jul; 74(7):1038-42. PubMed ID: 12931767
[TBL] [Abstract][Full Text] [Related]
38. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
Kooistra KL; Rodriguez M; Powis G
Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
[TBL] [Abstract][Full Text] [Related]
39. Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats.
Chekhun VF; Storchai DM; Todor IN; Borikun TV; Lukianova NY
Exp Oncol; 2018 Oct; 40(3):200-204. PubMed ID: 30284996
[TBL] [Abstract][Full Text] [Related]
40. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate.
Sugimoto M; Futaki N; Harada M; Kaku S
Bone; 2013 Jan; 52(1):181-8. PubMed ID: 23041510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
